Skip to main content

Salvador Aznar Benitah receives an award for his research on cancer

Institutional
28 Dec 16

Images

Participants

Contact

Image
Communication Officer
Tel.+34 93 40 37255

The VI National 'Doctores Diz Pintado' Cancer Research Prize acknowledges his work and scientific career.

Salvador Aznar Benitah, ICREA researcher and group leader of the Stem Cells and Cancer Laboratory at IRB Barcelona, has been awarded the National 'Doctores Diz Pintado 2016' Cancer Research Prize. This distinction has been given in recognition of Salvador Aznar’s contributions to transferring knowledge from basic research to clinical research.  The award coincides with the recent publication of his study in Nature, which has identified the cells responsible for initiating and promoting metastasis in several types of human tumour.

The National 'Doctores Diz Pintado' Cancer Research Prize, named after the doctors Manuel and Alfonso Diz Pintado, is given by the "Fundación de Investigación del Cáncer de la Universidad de la Salamanca (FICUS) – Centro de Investigación del Cáncer (CIC)" with the aim to promote and award the work of young Spanish scientists in oncology research.

Research interests

The research developed by Salvador Aznar Benitah is mainly basic; however, it pursues clinical application thanks to the combination of several methodologies that allows systematic study of the molecular mechanisms underlying tumour growth.

His research group aims to characterize the molecular pathways that regulate the behaviour of normal stem cells during homeostasis and to determine how they become deregulated during carcinogenesis and ageing.

On 28 January, in an academic ceremony organised by the University of Salamanca on the occasion of the day of “Saint Thomas of Aquino”, Salvador Aznar Benitah will be presented with the VI National 'Doctores Diz Pintado' Cancer Research Prize.

This is the second time an IRB Barcelona’s researcher has won this award. Eduard Batlle, coordinator of the Oncology Programme at IRB Barcelona and head of the Colorectal Cancer Laboratory at the same institute, received it in 2014.

About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 27 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).